157 related articles for article (PubMed ID: 33474593)
21. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
[TBL] [Abstract][Full Text] [Related]
22. Targeting the cytochrome bc
Wani MA; Dhaked DK
Mol Divers; 2022 Oct; 26(5):2949-2965. PubMed ID: 34762234
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and anti-mycobacterial evaluation of imidazo[1,2-
Khetmalis YM; Chitti S; Umarani Wunnava A; Karan Kumar B; Murali Krishna Kumar M; Murugesan S; Chandra Sekhar KVG
RSC Med Chem; 2022 Mar; 13(3):327-342. PubMed ID: 35434623
[TBL] [Abstract][Full Text] [Related]
24. Quantum modelling and molecular docking evaluation of some selected quinoline derivatives as anti-tubercular agents.
Adeniji SE; Adamu Shallangwa G; Ebuka Arthur D; Abdullahi M; Mahmoud AY; Haruna A
Heliyon; 2020 Mar; 6(3):e03639. PubMed ID: 32258484
[No Abstract] [Full Text] [Related]
25. Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach.
Uddin R; Siddiqui QN; Azam SS; Saima B; Wadood A
Eur J Pharm Sci; 2018 Mar; 114():13-23. PubMed ID: 29174549
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
[TBL] [Abstract][Full Text] [Related]
27. Arabinosyltransferase C enzyme of
Das N; Jena PK; Pradhan SK
Heliyon; 2020 Feb; 6(2):e02693. PubMed ID: 32090179
[TBL] [Abstract][Full Text] [Related]
28. Structure-based discovery of novel inhibitors of Mycobacterium tuberculosis CYP121 from Indonesian natural products.
Prasasty VD; Cindana S; Ivan FX; Zahroh H; Sinaga E
Comput Biol Chem; 2020 Apr; 85():107205. PubMed ID: 31981965
[TBL] [Abstract][Full Text] [Related]
29. Homology modeling and molecular dynamic simulation of UDP-N-acetylmuramoyl-l-alanine-d-glutamate ligase (MurD) from Mycobacterium tuberculosis H37Rv using in silico approach.
Isa MA
Comput Biol Chem; 2019 Feb; 78():116-126. PubMed ID: 30504089
[TBL] [Abstract][Full Text] [Related]
30. Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
Venugopala KN; Chandrashekharappa S; Pillay M; Abdallah HH; Mahomoodally FM; Bhandary S; Chopra D; Attimarad M; Aldhubiab BE; Nair AB; Sreeharsha N; Morsy MA; Pottathil S; Venugopala R; Odhav B; Mlisana K
PLoS One; 2019; 14(6):e0217270. PubMed ID: 31163040
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Sriram D; Yogeeswari P; Sridevi JP; Guru Row TN; Hosamani AA; Sujan Ganapathy PS; Chandrika N; Narendra LV
Eur J Med Chem; 2015 Jan; 89():616-27. PubMed ID: 25462270
[TBL] [Abstract][Full Text] [Related]
32. Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae.
Kaur G; Pandey B; Kumar A; Garewal N; Grover A; Kaur J
J Biomol Struct Dyn; 2019 Mar; 37(5):1254-1269. PubMed ID: 29557724
[TBL] [Abstract][Full Text] [Related]
33. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase.
Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY
Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857
[TBL] [Abstract][Full Text] [Related]
34. Molecular Informatics Studies of the Iron-Dependent Regulator (ideR) Reveal Potential Novel Anti-
Kwofie SK; Enninful KS; Yussif JA; Asante LA; Adjei M; Kan-Dapaah K; Tiburu EK; Mensah WA; Miller WA; Mosi L; Wilson MD
Molecules; 2019 Jun; 24(12):. PubMed ID: 31234337
[TBL] [Abstract][Full Text] [Related]
35. Inhibitor binding studies of
Mallavarapu BD; Abdullah M; Saxena S; Guruprasad L
J Biomol Struct Dyn; 2019 Sep; 37(14):3751-3763. PubMed ID: 30239262
[TBL] [Abstract][Full Text] [Related]
36. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
[TBL] [Abstract][Full Text] [Related]
37. Improved Phenoxyalkylbenzimidazoles with Activity against Mycobacterium tuberculosis Appear to Target QcrB.
Chandrasekera NS; Berube BJ; Shetye G; Chettiar S; O'Malley T; Manning A; Flint L; Awasthi D; Ioerger TR; Sacchettini J; Masquelin T; Hipskind PA; Odingo J; Parish T
ACS Infect Dis; 2017 Dec; 3(12):898-916. PubMed ID: 29035551
[TBL] [Abstract][Full Text] [Related]
38. In silico and in vitro study of Mycobacterium tuberculosis H37Rv uncharacterized protein (RipD): an insight on tuberculosis therapeutics.
Arega AM; Dhal AK; Nayak S; Mahapatra RK
J Mol Model; 2022 May; 28(6):171. PubMed ID: 35624324
[TBL] [Abstract][Full Text] [Related]
39. Identification of some novel pyrazolo[1,5-a]pyrimidine derivatives as InhA inhibitors through pharmacophore-based virtual screening and molecular docking.
Modi P; Patel S; Chhabria MT
J Biomol Struct Dyn; 2019 Apr; 37(7):1736-1749. PubMed ID: 29663870
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
